Former Mangaluru Mayor Ashraf joins Congress party once again!

Bengaluru, Mar 29: The State government launched a mobile application for people to track the movement history of patients, who tested positive, before their detection so that they can take precautions. The app will give the date and time of visit to spots by the patients.

The mobile app “Corona Watch” can be downloaded from Google Playstore https://play.google.com/store/apps/details?id=com.ksrsac.drawshapefile

“The app also has a list of government designated first response hospitals for COVID-19 where citizen with symptoms can go. However, before going to a COVID hospital, people should call helplines — 104, 080-46848600 or 080-66692000,” said a message by Munish Moudgil, secretary, Administrative Reforms, who is also in-charge of the State COVID war room.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bengaluru, Jun 9: Two grassroots level workers of the Bharatiya Janata Party (BJP) on Tuesday filed their nominations for the Rajya Sabha elections from Karnataka, Chief Minister and senior BJP leader BS Yediyurappa said.

"Eranna Kadadi and Ashok Gasti have filed nominations for the Rajya Sabha elections from Karnataka. It is only in BJP that grassroots level workers are given recognition," Yediyurappa told reporters here.

The elections to fill the vacant 18 Rajya Sabha seats from seven states are scheduled to be held on June 19. Elections to four Rajya Sabha seats will be held in Karnataka.

"The core committee of the party had recommended a few names. Afterwards, the party's all-India president consulted with me. Finally, these two names were finalised," Yediyurappa said.

The nominations will be scrutinised on Wednesday and the last date for withdrawal of nomination is June 12.

Notably, the Janata Dal (Secular) on Monday announced that party supremo and former Prime Minister HD Deve Gowda has decided to contest the forthcoming Rajya Sabha elections.